ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 487,65
-0,21%
Dow Jones
38 589,16
-0,15%
DAX
17 978,72
-0,23%
Brent Oil
82,215
0,11%
Bitcoin
65 715,81
-1,39%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Evogene Ltd (EVGN)

  7. Evogene Ltd (EVGN) Actualités

EVGN

Evogene (EVGN)

Evogene Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:EVGN
DateHeureSourceTitreSymboleSociété
06/06/202422h02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVGNEvogene Ltd
23/05/202417h00PR Newswire (US)Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & MelanomaNASDAQ:EVGNEvogene Ltd
23/05/202413h00PR Newswire (US)Evogene Reports First Quarter 2024 Financial ResultsNASDAQ:EVGNEvogene Ltd
21/05/202413h03PR Newswire (US)Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor SeedsNASDAQ:EVGNEvogene Ltd
09/05/202413h00PR Newswire (US)Evogene Schedules First Quarter 2024 Financial Results ReleaseNASDAQ:EVGNEvogene Ltd
16/04/202413h00PR Newswire (US)Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual MeetingNASDAQ:EVGNEvogene Ltd
11/04/202413h00PR Newswire (US)Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual MeetingNASDAQ:EVGNEvogene Ltd
02/04/202413h00PR Newswire (US)Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food IndustryNASDAQ:EVGNEvogene Ltd
28/03/202414h00PR Newswire (US)Evogene Announces Filing of Annual Report on Form 20-FNASDAQ:EVGNEvogene Ltd
20/03/202414h00PR Newswire (US)Evogene Reports Receipt of Nasdaq Minimum Bid Price NotificationNASDAQ:EVGNEvogene Ltd
19/03/202414h00PR Newswire (US)Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse TestingNASDAQ:EVGNEvogene Ltd
13/03/202414h00PR Newswire (US)Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North AmericaNASDAQ:EVGNEvogene Ltd
07/03/202413h00PR Newswire (US)Evogene Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:EVGNEvogene Ltd
06/03/202413h00PR Newswire (US)AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel HerbicidesNASDAQ:EVGNEvogene Ltd
05/03/202413h00PR Newswire (US)Casterra Announces New Agreements with Seed Producers in Brazil and Africa to Meet Growing Demand for its Elite Castor Seed VarietiesNASDAQ:EVGNEvogene Ltd
01/03/202413h03Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:EVGNEvogene Ltd
28/02/202413h00PR Newswire (US)Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement RequirementsNASDAQ:EVGNEvogene Ltd
26/02/202413h00PR Newswire (US)Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024NASDAQ:EVGNEvogene Ltd
22/02/202413h00PR Newswire (US)AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive OfficerNASDAQ:EVGNEvogene Ltd
21/02/202413h00PR Newswire (US)AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control SolutionNASDAQ:EVGNEvogene Ltd
20/02/202413h00PR Newswire (US)Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-InsecticideNASDAQ:EVGNEvogene Ltd
15/02/202402h30Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:EVGNEvogene Ltd
06/02/202413h08PR Newswire (US)Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic InnovationNASDAQ:EVGNEvogene Ltd
23/01/202413h00PR Newswire (US)Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement SummitNASDAQ:EVGNEvogene Ltd
17/01/202413h00PR Newswire (US)Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology DrugNASDAQ:EVGNEvogene Ltd
21/12/202313h00PR Newswire (US)Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024NASDAQ:EVGNEvogene Ltd
19/12/202313h00PR Newswire (US)Casterra Appoints New CEO and Expands Team to Drive Growth and InnovationNASDAQ:EVGNEvogene Ltd
05/12/202313h00PR Newswire (US)Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™NASDAQ:EVGNEvogene Ltd
28/11/202313h00PR Newswire (US)Lavie Bio Announces Expansion of its Bio-Inoculant Product for Spring Wheat, Yalos™, to Durum and BarleyNASDAQ:EVGNEvogene Ltd
15/11/202313h00PR Newswire (US)Evogene Reports Third Quarter 2023 Financial ResultsNASDAQ:EVGNEvogene Ltd
 Showing the most relevant articles for your search:NASDAQ:EVGN

Dernières Valeurs Consultées

EU
C158S
C158S
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés